Why the study?
Given the increasing burden of ASCVD in China, breakthrough lipid research worldwide, and varying target lipid levels by ASCVD risk, a revision of the guidelines was imperative.
Population
Individuals across various age groups, from children to the elderly, in China
Design
Clinical practice guideline
Authors
Loading...
Updates Chinese lipid targets amid rising ASCVD burden; leaves open optimal thresholds pending local validation studies.
Key points are not available for this paper at this time.
Li et al. (2023) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: